By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Asterand said today that it has won a contract from the National Institutes of Health valued at up to $24.3 million to support The Cancer Genome Atlas program.

Under the National Cancer Institute contract, which gives Asterand $5.4 million over a 17-month period and includes an option for renewal, the firm will supply clinically annotated human biospecimens to NCI for use in TCGA projects.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Even when given the option, not too many authors choose double-blinded peer-review for their manuscripts, ScienceInsider reports.

In PNAS this week: transcriptional read-through in stressed cells, genome stability role for the epigenetic regulator CTCF, and more.

The Save the Redwoods League is teaming with researchers to sequence the genomes of the coast redwood and giant sequoia.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.